APA (7th ed.) Citation

Zhihao Zhang, Xin Zhao, & Jie Chen. (2024). Adjuvant and neoadjuvant therapy with or without CDK4/6 inhibitors in HR+/HER2- early breast cancer: A systematic review and meta-analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Zhihao Zhang, Xin Zhao, and Jie Chen. Adjuvant and Neoadjuvant Therapy with or Without CDK4/6 Inhibitors in HR+/HER2- Early Breast Cancer: A Systematic Review and Meta-analysis. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Zhihao Zhang, et al. Adjuvant and Neoadjuvant Therapy with or Without CDK4/6 Inhibitors in HR+/HER2- Early Breast Cancer: A Systematic Review and Meta-analysis. Frontiers Media S.A., 2024.